Friulchem SpA engages in the research and development of pharmaceutical products for third party contract development and manufacturing organizations. It operates through the Veterinary and Human business units. The Veterinary business unit focuses on the processing of active pharmaceutical ingredients such as granules and powders to produce semi-finished and finished antibiotics. The Human unit specializes in the provides generic drug equivalent solutions to licensees. The company was founded by Alessandro Mazzola on January 22, 1996 and is headquartered in Milan, Italy.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company